Healthcare Business News
 

J&J said to face demand to lift Risperdal settlement offer by $800 million


By Bloomberg.com
Posted: March 12, 2012 - 1:45 pm ET
Tags:

Johnson & Johnson faces a U.S. government demand to raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing of the anti-psychotic Risperdal, according to three people familiar with the matter.

READ MORE »


Advertisement | View Media Kit

 


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.